Showing results (111-120 of 153) with videos related to
Sort By:
Pageof 16
Surgical Endoscopy|March 26, 2005
Minimally invasive incisional herniorrhaphy: a review of 208 casesC T Frantzides, M A Carlson, J G Zografakis, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1984
A two-stage mouse skin carcinogenesis study of lyngbyatoxin AH Fujiki, M Suganuma, H Hakii, et al.Oncology Research|January 1, 1994
Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural productC D Smith, M R Prinsep, F R Caplan, et al.Bone and Mineral|December 1, 1993
Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ cultureR E Moore, C K Smith, C S Bailey, et al.Comparative Biochemistry and Physiology. A, Comparative Physiology|January 1, 1988
Hormonal regulation of preputial gland function in male Microtus montanus, the montane voleC N Rowsemitt, C J Welsh, M C Kuehl, et al.Journal of Pediatric Gastroenterology and Nutrition|January 1, 1989
Longitudinal assessment of type I procollagen in children with inflammatory bowel disease subjected to surgeryJ S Hyams, R E Moore, A M Leichtner, et al.Planta Medica|April 1, 1993
Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (cyanophyta)A F Lau, J Siedlecki, J Anleitner, et al.Psychiatry Research|May 16, 2000
Seasonal variations in internalizing, externalizing, and substance use disorders in youthP A Kovalenko, C W Hoven, J Wicks, et al.Molecular Pharmacology|October 1, 1991
Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatasesR E Honkanen, M Dukelow, J Zwiller, et al.Journal of Natural Products|April 28, 1999
Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.Pageof 16